Selected research
Industry Growth & Trends
Global Histone Methyltransferases Industry Growth and Trends Forecast to 2032
Market perspective
The global Histone Methyltransferases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Histone Methyltransferases include Eisai Co., Ltd., Pfizer, Glaxosmithkline (Gsk), Sirtris, Sigma-Aldrich, Sequenom, Inc., Ribomed Biotechnologies, Inc., Reaction Biology Corp. and Rana Therapeutics Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Histone Methyltransferases market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Histone Methyltransferases market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Histone Methyltransferases market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Histone Methyltransferases.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Histone Methyltransferases market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Histone Methyltransferases Market by Company
Eisai Co., Ltd.
Pfizer
Glaxosmithkline (Gsk)
Sirtris
Sigma-Aldrich
Sequenom, Inc.
Ribomed Biotechnologies, Inc.
Reaction Biology Corp.
Rana Therapeutics Inc.
Prognosdx Health, Inc.
Pharmacyclics, Inc
Epizyme, Inc.
Epitherapeutics APS
Domainex
Constellation Pharmaceuticals
Cellcentric Ltd.
Histone Methyltransferases Segment by Type
EZ
RIZ
SET1
SET2
SMYD
SUV39
SUV4-20
Histone Methyltransferases Segment by Application
Breast Cancer
Liver Cancer
Lung Cancer
Others
Histone Methyltransferases Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Methyltransferases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Histone Methyltransferases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Methyltransferases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Histone Methyltransferases manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Histone Methyltransferases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- EZ
- RIZ
- SET1
- SET2
- SMYD
- SUV39
- SUV4-20
Applications
- Breast Cancer
- Liver Cancer
- Lung Cancer
- Others
Companies covered
- Eisai Co., Ltd.
- Pfizer
- Glaxosmithkline (Gsk)
- Sirtris
- Sigma-Aldrich
- Sequenom, Inc.
- Ribomed Biotechnologies, Inc.
- Reaction Biology Corp.
- Rana Therapeutics Inc.
- Prognosdx Health, Inc.
- Pharmacyclics, Inc
- Epizyme, Inc.
- Epitherapeutics APS
- Domainex
- Constellation Pharmaceuticals
- Cellcentric Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Histone Methyltransferases Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Histone Methyltransferases Sales Estimates and Forecasts (2021-2032)
- 1.3 Histone Methyltransferases Market by Type
- 1.3.1 EZ
- 1.3.2 RIZ
- 1.3.3 SET1
- 1.3.4 SET2
- 1.3.5 SMYD
- 1.3.6 SUV39
- 1.3.7 SUV4-20
- 1.4 Global Histone Methyltransferases Market Size by Type
- 1.4.1 Global Histone Methyltransferases Market Size Overview by Type (2021-2032)
- 1.4.2 Global Histone Methyltransferases Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Histone Methyltransferases Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Histone Methyltransferases Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Histone Methyltransferases Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Histone Methyltransferases Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Histone Methyltransferases Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Histone Methyltransferases Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Histone Methyltransferases Industry Trends
- 2.2 Histone Methyltransferases Industry Drivers
- 2.3 Histone Methyltransferases Industry Opportunities and Challenges
- 2.4 Histone Methyltransferases Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Histone Methyltransferases Revenue (2021-2026)
- 3.2 Global Top Players by Histone Methyltransferases Sales (2021-2026)
- 3.3 Global Top Players by Histone Methyltransferases Price (2021-2026)
- 3.4 Global Histone Methyltransferases Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Histone Methyltransferases Major Company Production Sites & Headquarters
- 3.6 Global Histone Methyltransferases Company, Product Type & Application
- 3.7 Global Histone Methyltransferases Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Histone Methyltransferases Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Histone Methyltransferases Players Market Share by Revenue in 2025
- 3.8.3 2025 Histone Methyltransferases Tier 1, Tier 2, and Tier 3
4 Histone Methyltransferases Regional Status and Outlook
- 4.1 Global Histone Methyltransferases Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Histone Methyltransferases Historic Market Size by Region
- 4.2.1 Global Histone Methyltransferases Sales in Volume by Region (2021-2026)
- 4.2.2 Global Histone Methyltransferases Sales in Value by Region (2021-2026)
- 4.2.3 Global Histone Methyltransferases Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Histone Methyltransferases Forecasted Market Size by Region
- 4.3.1 Global Histone Methyltransferases Sales in Volume by Region (2027-2032)
- 4.3.2 Global Histone Methyltransferases Sales in Value by Region (2027-2032)
- 4.3.3 Global Histone Methyltransferases Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Histone Methyltransferases by Application
- 5.1 Histone Methyltransferases Market by Application
- 5.1.1 Breast Cancer
- 5.1.2 Liver Cancer
- 5.1.3 Lung Cancer
- 5.1.4 Others
- 5.2 Global Histone Methyltransferases Market Size by Application
- 5.2.1 Global Histone Methyltransferases Market Size Overview by Application (2021-2032)
- 5.2.2 Global Histone Methyltransferases Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Histone Methyltransferases Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Histone Methyltransferases Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Histone Methyltransferases Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Histone Methyltransferases Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Histone Methyltransferases Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Histone Methyltransferases Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Eisai Co., Ltd.
- 6.1.1 Eisai Co., Ltd. Company Information
- 6.1.2 Eisai Co., Ltd. Business Overview
- 6.1.3 Eisai Co., Ltd. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Eisai Co., Ltd. Histone Methyltransferases Product Portfolio
- 6.1.5 Eisai Co., Ltd. Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Pfizer Histone Methyltransferases Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 Glaxosmithkline (Gsk)
- 6.3.1 Glaxosmithkline (Gsk) Company Information
- 6.3.2 Glaxosmithkline (Gsk) Business Overview
- 6.3.3 Glaxosmithkline (Gsk) Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Glaxosmithkline (Gsk) Histone Methyltransferases Product Portfolio
- 6.3.5 Glaxosmithkline (Gsk) Recent Developments
- 6.4 Sirtris
- 6.4.1 Sirtris Company Information
- 6.4.2 Sirtris Business Overview
- 6.4.3 Sirtris Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sirtris Histone Methyltransferases Product Portfolio
- 6.4.5 Sirtris Recent Developments
- 6.5 Sigma-Aldrich
- 6.5.1 Sigma-Aldrich Company Information
- 6.5.2 Sigma-Aldrich Business Overview
- 6.5.3 Sigma-Aldrich Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sigma-Aldrich Histone Methyltransferases Product Portfolio
- 6.5.5 Sigma-Aldrich Recent Developments
- 6.6 Sequenom, Inc.
- 6.6.1 Sequenom, Inc. Company Information
- 6.6.2 Sequenom, Inc. Business Overview
- 6.6.3 Sequenom, Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sequenom, Inc. Histone Methyltransferases Product Portfolio
- 6.6.5 Sequenom, Inc. Recent Developments
- 6.7 Ribomed Biotechnologies, Inc.
- 6.7.1 Ribomed Biotechnologies, Inc. Company Information
- 6.7.2 Ribomed Biotechnologies, Inc. Business Overview
- 6.7.3 Ribomed Biotechnologies, Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Ribomed Biotechnologies, Inc. Histone Methyltransferases Product Portfolio
- 6.7.5 Ribomed Biotechnologies, Inc. Recent Developments
- 6.8 Reaction Biology Corp.
- 6.8.1 Reaction Biology Corp. Company Information
- 6.8.2 Reaction Biology Corp. Business Overview
- 6.8.3 Reaction Biology Corp. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Reaction Biology Corp. Histone Methyltransferases Product Portfolio
- 6.8.5 Reaction Biology Corp. Recent Developments
- 6.9 Rana Therapeutics Inc.
- 6.9.1 Rana Therapeutics Inc. Company Information
- 6.9.2 Rana Therapeutics Inc. Business Overview
- 6.9.3 Rana Therapeutics Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Rana Therapeutics Inc. Histone Methyltransferases Product Portfolio
- 6.9.5 Rana Therapeutics Inc. Recent Developments
- 6.10 Prognosdx Health, Inc.
- 6.10.1 Prognosdx Health, Inc. Company Information
- 6.10.2 Prognosdx Health, Inc. Business Overview
- 6.10.3 Prognosdx Health, Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Prognosdx Health, Inc. Histone Methyltransferases Product Portfolio
- 6.10.5 Prognosdx Health, Inc. Recent Developments
- 6.11 Pharmacyclics, Inc
- 6.11.1 Pharmacyclics, Inc Company Information
- 6.11.2 Pharmacyclics, Inc Business Overview
- 6.11.3 Pharmacyclics, Inc Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Pharmacyclics, Inc Histone Methyltransferases Product Portfolio
- 6.11.5 Pharmacyclics, Inc Recent Developments
- 6.12 Epizyme, Inc.
- 6.12.1 Epizyme, Inc. Company Information
- 6.12.2 Epizyme, Inc. Business Overview
- 6.12.3 Epizyme, Inc. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Epizyme, Inc. Histone Methyltransferases Product Portfolio
- 6.12.5 Epizyme, Inc. Recent Developments
- 6.13 Epitherapeutics APS
- 6.13.1 Epitherapeutics APS Company Information
- 6.13.2 Epitherapeutics APS Business Overview
- 6.13.3 Epitherapeutics APS Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Epitherapeutics APS Histone Methyltransferases Product Portfolio
- 6.13.5 Epitherapeutics APS Recent Developments
- 6.14 Domainex
- 6.14.1 Domainex Company Information
- 6.14.2 Domainex Business Overview
- 6.14.3 Domainex Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Domainex Histone Methyltransferases Product Portfolio
- 6.14.5 Domainex Recent Developments
- 6.15 Constellation Pharmaceuticals
- 6.15.1 Constellation Pharmaceuticals Company Information
- 6.15.2 Constellation Pharmaceuticals Business Overview
- 6.15.3 Constellation Pharmaceuticals Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Constellation Pharmaceuticals Histone Methyltransferases Product Portfolio
- 6.15.5 Constellation Pharmaceuticals Recent Developments
- 6.16 Cellcentric Ltd.
- 6.16.1 Cellcentric Ltd. Company Information
- 6.16.2 Cellcentric Ltd. Business Overview
- 6.16.3 Cellcentric Ltd. Histone Methyltransferases Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Cellcentric Ltd. Histone Methyltransferases Product Portfolio
- 6.16.5 Cellcentric Ltd. Recent Developments
7 North America by Country
- 7.1 North America Histone Methyltransferases Sales by Country
- 7.1.1 North America Histone Methyltransferases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Histone Methyltransferases Sales by Country (2021-2026)
- 7.1.3 North America Histone Methyltransferases Sales Forecast by Country (2027-2032)
- 7.2 North America Histone Methyltransferases Market Size by Country
- 7.2.1 North America Histone Methyltransferases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Histone Methyltransferases Market Size by Country (2021-2026)
- 7.2.3 North America Histone Methyltransferases Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Histone Methyltransferases Sales by Country
- 8.1.1 Europe Histone Methyltransferases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Histone Methyltransferases Sales by Country (2021-2026)
- 8.1.3 Europe Histone Methyltransferases Sales Forecast by Country (2027-2032)
- 8.2 Europe Histone Methyltransferases Market Size by Country
- 8.2.1 Europe Histone Methyltransferases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Histone Methyltransferases Market Size by Country (2021-2026)
- 8.2.3 Europe Histone Methyltransferases Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Histone Methyltransferases Sales by Country
- 9.1.1 Asia-Pacific Histone Methyltransferases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Histone Methyltransferases Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Histone Methyltransferases Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Histone Methyltransferases Market Size by Country
- 9.2.1 Asia-Pacific Histone Methyltransferases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Histone Methyltransferases Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Histone Methyltransferases Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Histone Methyltransferases Sales by Country
- 10.1.1 South America Histone Methyltransferases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Histone Methyltransferases Sales by Country (2021-2026)
- 10.1.3 South America Histone Methyltransferases Sales Forecast by Country (2027-2032)
- 10.2 South America Histone Methyltransferases Market Size by Country
- 10.2.1 South America Histone Methyltransferases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Histone Methyltransferases Market Size by Country (2021-2026)
- 10.2.3 South America Histone Methyltransferases Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Histone Methyltransferases Sales by Country
- 11.1.1 Middle East and Africa Histone Methyltransferases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Histone Methyltransferases Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Histone Methyltransferases Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Histone Methyltransferases Market Size by Country
- 11.2.1 Middle East and Africa Histone Methyltransferases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Histone Methyltransferases Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Histone Methyltransferases Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Histone Methyltransferases Value Chain Analysis
- 12.1.1 Histone Methyltransferases Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Histone Methyltransferases Production Mode & Process
- 12.2 Histone Methyltransferases Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Histone Methyltransferases Distributors
- 12.2.3 Histone Methyltransferases Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst